Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses
Research and development	$ 16,484	$ 25,266
General and administrative	4,665	5,104
Total operating expenses	21,149	30,370
Loss from operations	(21,149)	(30,370)
Other income (expense)
Interest income	1,064	2,471
Interest expense	(1,069)	(1,023)
Change in fair value of embedded derivatives	460	190
Other expense, net	(43)	(64)
Total other income	412	1,574
Net loss	(20,737)	(28,796)
Other comprehensive gain (loss)
Unrealized (loss) gain on marketable securities	(62)	63
Comprehensive loss	$ (20,799)	$ (28,733)
Net loss per common share, basic (in dollars per share)	$ (0.33)	$ (0.48)
Net loss per common share, diluted (in dollars per share)	$ (0.33)	$ (0.48)
Weighted-average shares outstanding, basic (in shares)	63,219,289	60,525,628
Weighted-average shares outstanding, diluted (in shares)	63,219,289	60,525,628